Clinical Chemistry and Laboratory Medicine (CCLM)
Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Editor-in-Chief: Plebani, Mario
Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.
IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition
SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238
Indicators and quality specifications for strategic and support processes related to the clinical laboratory: four years' experience
1Laboratori Clínic L'Hospitalet, ICS-Metropolitana Sud, Barcelona, Spain
2Laboratori Clínic Barcelonès Nord i Vallès Oriental, ICS-Metropolitana Nord, Spain
3Servei de Bioquímica Clínica Hospital Germans Trias i Pujol, ICS-Metropolitana Nord, Spain
4Laboratori Clínic Bages, ICS-Catalunya Central, Spain
5Laboratori Clínic Hospital Verge de la Cinta, ICS-Terres de l'Ebre, Spain
6Laboratori Clínic Berguedà, ICS-Catalunya Central, Spain
7Laboratori Clínic Hospital Arnau de Vilanova, ICS-Lleida, Spain
8Laboratori Clínic Hospital Dr. Josep Trueta, ICS-Girona, Spain
9Laboratori Clínic Manso, ICS-Barcelona, Spain
10Laboratori Clínic Bon Pastor, ICS-Barcelona, Spain
11Laboratori Clínic Hospital Joan XXIII, ICS-Tarragona, Spain
12Laboratoris Clínics Hospital Vall d'Hebron, ICS-Barcelona, Spain
13Consorci de Laboratori Intercomarcal, ICS-Catalunya Central, Spain
Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 48, Issue 7, Pages 1015–1019, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2010.229, May 2010
- Published Online:
Background: Quality specifications for indicators of the key analytic processes have been defined by international consensus. However, only preliminary specifications for laboratory-related strategic and support processes have been developed. The present study attempts to increase the robustness of the preliminary proposed specifications.
Methods: Recovering records and incidences occurred over a 4-year follow-up period, for 12 indicators, used in all laboratories from this group regarding strategic and support processes.
Results and conclusions: The results obtained indicate that it is better to establish an interval rather than a fixed value for the majority of indicators. Longer studies are needed to properly assess some quality specifications, and data recording system must be standardized in others. Additional, multicenter studies are needed to establish more robust specifications and determine the state of the art of laboratories in other settings.
Clin Chem Lab Med 2010;48:1015–9.
Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.